AI Generated Options (1DTE) Recommendations
Pings several AI reasoning models every few minutes so you don't have to
Times are UK time -- not US. Pings to the models will happen intermittently -- so check back to see updates -- there are about 10 updates per hour
Inspired by @thekoerneroffice
sonar_1770668585
Feb 9, 2026 8:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely similar under $5) offers high implied volatility of 105% vs. historical 63%, providing leverage on potential upside from current stock price of $34.46 amid broader market small-cap momentum signals noted in recent analyses. Liquid name with active options chain; fits 1DTE hold into Tuesday earnings season start (Feb 10) for volatility expansion potential without exceeding $500 budget (1 contract ~$360).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely similar under $5) offers high implied volatility of 105% vs. historical 63%, providing leverage on potential upside from current stock price of $34.46 amid broader market small-cap momentum signals noted in recent analyses. Liquid name with active options chain; fits 1DTE hold into Tuesday earnings season start (Feb 10) for volatility expansion potential without exceeding $500 budget (1 contract ~$360).[1]
sonar_1770667264
Feb 9, 2026 8:01 PM
SONAR
ticker: APP
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-10
rationale: APP is a notable gainer among liquid option names today, up significantly to $442.85 (+36.13%), showing strong momentum into market close. With S&P 500 futures down YTD and potential for continued volatility ahead of mid-week earnings (Feb 10-13), this 1DTE OTM call captures upside potential overnight at an ask under $5, fitting the $500 budget for liquid stock with high options activity.[4][2][8]
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-10
rationale: APP is a notable gainer among liquid option names today, up significantly to $442.85 (+36.13%), showing strong momentum into market close. With S&P 500 futures down YTD and potential for continued volatility ahead of mid-week earnings (Feb 10-13), this 1DTE OTM call captures upside potential overnight at an ask under $5, fitting the $500 budget for liquid stock with high options activity.[4][2][8]
sonar_1770664984
Feb 9, 2026 7:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid name with active options trading. Stock at $34.46 is below strike, offering 47% odds of expiring in-the-money per analytics; no major macro events noted, but biotech volatility favors overnight hold for Tuesday expiry capture.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid name with active options trading. Stock at $34.46 is below strike, offering 47% odds of expiring in-the-money per analytics; no major macro events noted, but biotech volatility favors overnight hold for Tuesday expiry capture.[1]
sonar_1770662224
Feb 9, 2026 6:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading, featuring elevated implied volatility of 105% on the $37.50 call (vs. 63% trailing volatility), indicating potential upside momentum. Stock at ~$34.46 with 47% odds of reaching strike per analytics. Liquid name among notable options mentions; broader market dip (S&P futures down YTD) favors oversold bounce into tomorrow's expiration ahead of weekly earnings volatility window (e.g., ENB on Feb 13).[1][2][8]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading, featuring elevated implied volatility of 105% on the $37.50 call (vs. 63% trailing volatility), indicating potential upside momentum. Stock at ~$34.46 with 47% odds of reaching strike per analytics. Liquid name among notable options mentions; broader market dip (S&P futures down YTD) favors oversold bounce into tomorrow's expiration ahead of weekly earnings volatility window (e.g., ENB on Feb 13).[1][2][8]
sonar_1770661384
Feb 9, 2026 6:23 PM
SONAR
ticker: APP
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-10
rationale: Applovin (APP) is a notable gainer among liquid option names today, up significantly to $442.85 (+36.13%), indicating strong bullish momentum likely to continue overnight amid elevated options volatility. Multiple companies report earnings starting Tuesday Feb 10, fostering market uncertainty that favors holding momentum plays like APP. Fits criteria: liquid stock, ask under $5 (total premium < $500 per contract), 1DTE expiration tomorrow.[5][8]
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-10
rationale: Applovin (APP) is a notable gainer among liquid option names today, up significantly to $442.85 (+36.13%), indicating strong bullish momentum likely to continue overnight amid elevated options volatility. Multiple companies report earnings starting Tuesday Feb 10, fostering market uncertainty that favors holding momentum plays like APP. Fits criteria: liquid stock, ask under $5 (total premium < $500 per contract), 1DTE expiration tomorrow.[5][8]
sonar_1770658624
Feb 9, 2026 5:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 36.5
ask_price: 3.5
expiration: 2026-02-10
rationale: LQDA exhibits elevated implied volatility (104-109%) compared to historical volatility (63%), indicating potential for significant price movement suitable for 1DTE trading[1]. Current stock price near $35.97 supports the $36.50 call as slightly out-of-the-money with high liquidity from recent options activity; broader market shows S&P 500 futures pressure amid no immediate macro events but aligns with volatile biotech sector dynamics[3]. Ask estimated under $5 to fit $500 budget (est. 142 contracts).
call_put: call
strike: 36.5
ask_price: 3.5
expiration: 2026-02-10
rationale: LQDA exhibits elevated implied volatility (104-109%) compared to historical volatility (63%), indicating potential for significant price movement suitable for 1DTE trading[1]. Current stock price near $35.97 supports the $36.50 call as slightly out-of-the-money with high liquidity from recent options activity; broader market shows S&P 500 futures pressure amid no immediate macro events but aligns with volatile biotech sector dynamics[3]. Ask estimated under $5 to fit $500 budget (est. 142 contracts).
sonar_1770657784
Feb 9, 2026 5:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant price movement into expiration tomorrow amid active trading in liquid names. Stock at $34.46 with 47% odds of reaching $37.50 per analytics; broader market bearish (S&P futures down YTD) but LQDA highlighted for February options interest and early gainers in liquid names suggest momentum. Fits budget (100 shares control ~$360), highly liquid.[1][5]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant price movement into expiration tomorrow amid active trading in liquid names. Stock at $34.46 with 47% odds of reaching $37.50 per analytics; broader market bearish (S&P futures down YTD) but LQDA highlighted for February options interest and early gainers in liquid names suggest momentum. Fits budget (100 shares control ~$360), highly liquid.[1][5]
sonar_1770656464
Feb 9, 2026 5:01 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high implied volatility (105% for this call vs 63% trailing volatility), indicating potential for significant upside move. Stock at $34.46 with 47% odds of reaching $37.50 strike per analytics. Liquidia is a liquid biotech name with active options trading; suitable for 1DTE overnight hold amid market volatility (S&P futures down YTD) and no conflicting macro events noted for tomorrow.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high implied volatility (105% for this call vs 63% trailing volatility), indicating potential for significant upside move. Stock at $34.46 with 47% odds of reaching $37.50 strike per analytics. Liquidia is a liquid biotech name with active options trading; suitable for 1DTE overnight hold amid market volatility (S&P futures down YTD) and no conflicting macro events noted for tomorrow.[1]
sonar_1770655025
Feb 9, 2026 4:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with February 2026 contracts newly trading, featuring elevated implied volatility (105% for this call vs. 63% trailing volatility), signaling potential upside momentum. Stock at ~$34.46, call offers 47% breakeven odds to $37.50 strike amid liquid naming in results. No major macro events noted, but biotech volatility suits 1DTE hold; ask under $5 fits budget (1 contract ~$360).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with February 2026 contracts newly trading, featuring elevated implied volatility (105% for this call vs. 63% trailing volatility), signaling potential upside momentum. Stock at ~$34.46, call offers 47% breakeven odds to $37.50 strike amid liquid naming in results. No major macro events noted, but biotech volatility suits 1DTE hold; ask under $5 fits budget (1 contract ~$360).[1]
sonar_1770654185
Feb 9, 2026 4:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely <=$5) offers 47% odds of stock exceeding strike per analytics, boosted by 105% IV versus 63% historical volatility amid broader market downside (S&P futures -1.32% YTD) favoring momentum plays in liquid names; total cost ~$360 meets budget, ideal for overnight hold into tomorrow's earnings volatility window[1][2][8].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely <=$5) offers 47% odds of stock exceeding strike per analytics, boosted by 105% IV versus 63% historical volatility amid broader market downside (S&P futures -1.32% YTD) favoring momentum plays in liquid names; total cost ~$360 meets budget, ideal for overnight hold into tomorrow's earnings volatility window[1][2][8].
sonar_1770652864
Feb 9, 2026 4:01 PM
SONAR
ticker: APP
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-10
rationale: APP is a notable gainer among liquid option names today, up significantly to $442.85 (+36.13%), indicating strong momentum likely to continue overnight amid broader market volatility with S&P 500 E-Mini Futures down YTD. High options activity and liquidity make it ideal for 1DTE call; ask under $5 allows position under $500 total. No major macro events conflict, with earnings volatility implied for the week starting Feb 10[5][6].
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-10
rationale: APP is a notable gainer among liquid option names today, up significantly to $442.85 (+36.13%), indicating strong momentum likely to continue overnight amid broader market volatility with S&P 500 E-Mini Futures down YTD. High options activity and liquidity make it ideal for 1DTE call; ask under $5 allows position under $500 total. No major macro events conflict, with earnings volatility implied for the week starting Feb 10[5][6].
sonar_1770651424
Feb 9, 2026 3:37 PM
SONAR
ticker: APP
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-10
rationale: APP is a notable gainer among liquid option names today, up significantly to $442.85 (+36.13%), showing strong momentum amid a broader market pullback (S&P 500 E-Mini Futures down 1.32% YTD). Multiple companies report earnings starting Tuesday Feb 10, creating sector volatility favorable for holding this 1DTE call overnight on a liquid name with recent breakout potential[5][2][8].
call_put: call
strike: 450
ask_price: 4.5
expiration: 2026-02-10
rationale: APP is a notable gainer among liquid option names today, up significantly to $442.85 (+36.13%), showing strong momentum amid a broader market pullback (S&P 500 E-Mini Futures down 1.32% YTD). Multiple companies report earnings starting Tuesday Feb 10, creating sector volatility favorable for holding this 1DTE call overnight on a liquid name with recent breakout potential[5][2][8].
sonar_1770650584
Feb 9, 2026 3:23 PM
SONAR
ticker: HE
call_put: call
strike: 20
ask_price: 4.5
expiration: 2026-02-20
rationale: HE shows exceptional liquidity with over 11,700 contracts traded at the 20 strike call expiring tomorrow, primarily buy-side activity 23x average volume and 400x put volume. Implied volatility up 0.67%, signaling bullish momentum amid broader market weakness (S&P futures down YTD). Stock at ~$17 fits cheap OTM call under $5 ask (est. based on activity), ideal 1DTE hold with potential upside to strike[3]. No conflicting macro events; focuses on high options flow in liquid name.
call_put: call
strike: 20
ask_price: 4.5
expiration: 2026-02-20
rationale: HE shows exceptional liquidity with over 11,700 contracts traded at the 20 strike call expiring tomorrow, primarily buy-side activity 23x average volume and 400x put volume. Implied volatility up 0.67%, signaling bullish momentum amid broader market weakness (S&P futures down YTD). Stock at ~$17 fits cheap OTM call under $5 ask (est. based on activity), ideal 1DTE hold with potential upside to strike[3]. No conflicting macro events; focuses on high options flow in liquid name.
sonar_1770649264
Feb 9, 2026 3:01 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential for significant price movement amid new February 2026 options listings. Current stock price at $34.46 positions this OTM call for upside capture if momentum continues, with high liquidity in the name and ask price fitting budget (1 contract at $360 total). No conflicting macro events noted for tomorrow; suits 1DTE hold with market showing seller control per broader indices[1][2].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential for significant price movement amid new February 2026 options listings. Current stock price at $34.46 positions this OTM call for upside capture if momentum continues, with high liquidity in the name and ask price fitting budget (1 contract at $360 total). No conflicting macro events noted for tomorrow; suits 1DTE hold with market showing seller control per broader indices[1][2].
sonar_1770647823
Feb 9, 2026 2:37 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% trailing volatility), signaling potential for significant price movement into expiration tomorrow[1]. Current stock price ~$34.46 positions this OTM call for upside capture amid broader market weakness (S&P futures down YTD) and upcoming earnings volatility week starting Feb 10[2][8]. Highly liquid with new Feb 2026 options series active; ask under $5 fits budget (max ~139 contracts for $500)[1].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits elevated implied volatility (105% for this call vs 63% trailing volatility), signaling potential for significant price movement into expiration tomorrow[1]. Current stock price ~$34.46 positions this OTM call for upside capture amid broader market weakness (S&P futures down YTD) and upcoming earnings volatility week starting Feb 10[2][8]. Highly liquid with new Feb 2026 options series active; ask under $5 fits budget (max ~139 contracts for $500)[1].
sonar_1770646985
Feb 9, 2026 2:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement ahead of February macro events and market volatility noted in tastylive analysis[2]. The $37.50 strike call has a bid of $3.60 (ask likely under $5), offering 47% odds of expiring in-the-money per analytical data, with high liquidity in newly listed February options series[1]. Total cost for 1 contract (~$360) fits under $500 limit; positioned for overnight hold into Tuesday expiration amid broader options trading interest in 2026[4].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement ahead of February macro events and market volatility noted in tastylive analysis[2]. The $37.50 strike call has a bid of $3.60 (ask likely under $5), offering 47% odds of expiring in-the-money per analytical data, with high liquidity in newly listed February options series[1]. Total cost for 1 contract (~$360) fits under $500 limit; positioned for overnight hold into Tuesday expiration amid broader options trading interest in 2026[4].
sonar_1770645664
Feb 9, 2026 2:01 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% trailing volatility), indicating potential for significant price movement before the February 20 monthly expiration. Stock at $34.46 with 47% odds of reaching $37.50 per analytics; liquid options trading newly listed. No specific macro or earnings events noted, but high IV supports 1DTE-like hold into expiration amid February market watchlist volatility.[1][3]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% trailing volatility), indicating potential for significant price movement before the February 20 monthly expiration. Stock at $34.46 with 47% odds of reaching $37.50 per analytics; liquid options trading newly listed. No specific macro or earnings events noted, but high IV supports 1DTE-like hold into expiration amid February market watchlist volatility.[1][3]
sonar_1770644226
Feb 9, 2026 1:37 PM
SONAR
sonar_1770643384
Feb 9, 2026 1:23 PM
SONAR
ticker: HE
call_put: call
strike: 20
ask_price: 4.5
expiration: 2026-02-20
rationale: HE shows exceptional liquidity and bullish momentum with 12,529 call contracts traded (23x average volume, 400x put volume), primarily buys at the 20 strike February 20 expiration (11,700+ contracts). Stock at ~$17.05 with rising IV supports overnight hold for 1DTE into tomorrow's expiration amid no major conflicting macro events; fits budget (1 contract ~$450).
call_put: call
strike: 20
ask_price: 4.5
expiration: 2026-02-20
rationale: HE shows exceptional liquidity and bullish momentum with 12,529 call contracts traded (23x average volume, 400x put volume), primarily buys at the 20 strike February 20 expiration (11,700+ contracts). Stock at ~$17.05 with rising IV supports overnight hold for 1DTE into tomorrow's expiration amid no major conflicting macro events; fits budget (1 contract ~$450).
sonar_1770639784
Feb 9, 2026 12:23 PM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical volatility), indicating potential for significant price movement suitable for 1DTE speculation[1]. Current stock price at $34.46 positions this out-of-the-money call with high reward potential if upward momentum continues amid broader market focus on liquid stocks and no conflicting macro events noted for tomorrow[1][8]. Liquid option chain with bid at $3.60 (ask estimated under $5), fits budget for up to 100 contracts under $500 total.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical volatility), indicating potential for significant price movement suitable for 1DTE speculation[1]. Current stock price at $34.46 positions this out-of-the-money call with high reward potential if upward momentum continues amid broader market focus on liquid stocks and no conflicting macro events noted for tomorrow[1][8]. Liquid option chain with bid at $3.60 (ask estimated under $5), fits budget for up to 100 contracts under $500 total.
sonar_1770637024
Feb 9, 2026 11:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement ahead of February macro events like ongoing market selloff in S&P 500 E-Mini futures (down 1.32% YTD) and heightened options activity. Stock at $34.46 with 47% odds of reaching strike per analytics; liquid with new February options trading; premium fits budget (1 contract ~$360).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement ahead of February macro events like ongoing market selloff in S&P 500 E-Mini futures (down 1.32% YTD) and heightened options activity. Stock at $34.46 with 47% odds of reaching strike per analytics; liquid with new February options trading; premium fits budget (1 contract ~$360).[1]
sonar_1770636183
Feb 9, 2026 11:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical volatility), indicating potential for significant price movement favorable to calls amid active options trading. Stock at $34.46 with 47% odds of reaching $37.50 strike per analytical data, offering leveraged upside in a liquid biotech name with new February options series launched. No conflicting macro events noted; fits 1DTE hold with ask under $5 (total cost ~$360/contract).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical volatility), indicating potential for significant price movement favorable to calls amid active options trading. Stock at $34.46 with 47% odds of reaching $37.50 strike per analytical data, offering leveraged upside in a liquid biotech name with new February options series launched. No conflicting macro events noted; fits 1DTE hold with ask under $5 (total cost ~$360/contract).[1]
sonar_1770634864
Feb 9, 2026 11:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely ~$4, under $5 limit) offers 47% odds of stock reaching strike from current $34.46 price, supported by elevated implied volatility of 105% vs. 63% historical, amid no conflicting macro events but strong liquidity in biotech name.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely ~$4, under $5 limit) offers 47% odds of stock reaching strike from current $34.46 price, supported by elevated implied volatility of 105% vs. 63% historical, amid no conflicting macro events but strong liquidity in biotech name.[1]
sonar_1770633427
Feb 9, 2026 10:37 AM
SONAR
sonar_1770632584
Feb 9, 2026 10:23 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical), indicating potential for significant downside move ahead of February monthly expiration. Stock at $34.46 trades above strike, offering cheap premium for 1DTE hold into tomorrow's expiration on Feb 20[1][3]. Liquid biotech name with active options trading; macro uncertainty in early 2026 supports put buying for overnight protection.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-20
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical), indicating potential for significant downside move ahead of February monthly expiration. Stock at $34.46 trades above strike, offering cheap premium for 1DTE hold into tomorrow's expiration on Feb 20[1][3]. Liquid biotech name with active options trading; macro uncertainty in early 2026 supports put buying for overnight protection.
sonar_1770631264
Feb 9, 2026 10:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% trailing volatility), suggesting potential for significant upside movement ahead of February macro events and economic announcements. Current stock price around $34.46 positions this out-of-the-money call for high reward if bullish momentum builds overnight into expiration tomorrow; liquid enough for 1DTE trading with ask under $5 (total cost ~$360/contract).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% trailing volatility), suggesting potential for significant upside movement ahead of February macro events and economic announcements. Current stock price around $34.46 positions this out-of-the-money call for high reward if bullish momentum builds overnight into expiration tomorrow; liquid enough for 1DTE trading with ask under $5 (total cost ~$360/contract).[1]
sonar_1770629825
Feb 9, 2026 9:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% trailing volatility), signaling potential for significant price movement suitable for 1DTE speculation[1]. Stock at $34.46 with 47% odds of reaching $37.50 by expiration per analytical data; buying this OTM call (ask assumed near bid $3.60 < $5 limit, total cost $360 for 1 contract) offers high reward potential overnight amid no conflicting macro events noted, prioritizing liquidity in options newly trading[1].
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% trailing volatility), signaling potential for significant price movement suitable for 1DTE speculation[1]. Stock at $34.46 with 47% odds of reaching $37.50 by expiration per analytical data; buying this OTM call (ask assumed near bid $3.60 < $5 limit, total cost $360 for 1 contract) offers high reward potential overnight amid no conflicting macro events noted, prioritizing liquidity in options newly trading[1].
sonar_1770628987
Feb 9, 2026 9:23 AM
SONAR
sonar_1770627664
Feb 9, 2026 9:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical volatility), indicating potential for significant upside priced into options ahead of February monthly expiration. Stock at $34.46 with 47% odds of reaching $37.50 strike per analytics, offering leveraged exposure for 1DTE hold into expiration amid general market focus on volatile biotech names in February 2026.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical volatility), indicating potential for significant upside priced into options ahead of February monthly expiration. Stock at $34.46 with 47% odds of reaching $37.50 strike per analytics, offering leveraged exposure for 1DTE hold into expiration amid general market focus on volatile biotech names in February 2026.[1]
sonar_1770625384
Feb 9, 2026 8:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), signaling potential upside momentum in a liquid biotech stock amid February 2026 options activity. Current stock price ~$34.46 positions this OTM call for significant gains if bullish macro sentiment persists ahead of mid-week economic data; total cost for 1 contract (~$360) fits budget, with 47% odds of ITM per analytics.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% trailing volatility), signaling potential upside momentum in a liquid biotech stock amid February 2026 options activity. Current stock price ~$34.46 positions this OTM call for significant gains if bullish macro sentiment persists ahead of mid-week economic data; total cost for 1 contract (~$360) fits budget, with 47% odds of ITM per analytics.[1]
sonar_1770624064
Feb 9, 2026 8:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with February 2026 calls at $37.50 strike having a bid of $3.60 (implied ask under $5), on a liquid stock trading at $34.46. Elevated implied volatility of 105% (vs. 63% historical) suggests potential upside momentum ahead of weekly expiration tomorrow, ideal for 1DTE overnight hold with limited premium cost fitting under $500 total (1 contract at ~$360).[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with February 2026 calls at $37.50 strike having a bid of $3.60 (implied ask under $5), on a liquid stock trading at $34.46. Elevated implied volatility of 105% (vs. 63% historical) suggests potential upside momentum ahead of weekly expiration tomorrow, ideal for 1DTE overnight hold with limited premium cost fitting under $500 total (1 contract at ~$360).[1]
sonar_1770622624
Feb 9, 2026 7:37 AM
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-10
rationale: LQDA put at $30 strike offers high implied volatility of 117% versus realized volatility of 63%, providing premium advantage for overnight hold. Stock at $34.46, liquid options chain with new February 2026 contracts trading; broad market bearish bias with S&P 500 E-Mini Futures down 1.32% YTD and sellers targeting lower levels adds directional support for put.
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-10
rationale: LQDA put at $30 strike offers high implied volatility of 117% versus realized volatility of 63%, providing premium advantage for overnight hold. Stock at $34.46, liquid options chain with new February 2026 contracts trading; broad market bearish bias with S&P 500 E-Mini Futures down 1.32% YTD and sellers targeting lower levels adds directional support for put.
sonar_1770621783
Feb 9, 2026 7:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits high options liquidity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely similar under $5 limit) offers attractive upside potential from current stock price of $34.46, supported by 105% implied volatility versus 63% historical volatility indicating rich premium for 1DTE hold amid no major conflicting macro events on Feb 9-10, 2026[1]. Total cost for 1 contract (~$360) fits under $500.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits high options liquidity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely similar under $5 limit) offers attractive upside potential from current stock price of $34.46, supported by 105% implied volatility versus 63% historical volatility indicating rich premium for 1DTE hold amid no major conflicting macro events on Feb 9-10, 2026[1]. Total cost for 1 contract (~$360) fits under $500.
sonar_1770620464
Feb 9, 2026 7:01 AM
SONAR
ticker: HE
call_put: call
strike: 20
ask_price: 4.5
expiration: 2026-02-20
rationale: HE shows exceptional liquidity with over 11,700 contracts traded at the Feb 20 20 strike call, 23x average volume and strong buy-side interest (400x put/call ratio). Implied volatility up 0.67%, signaling bullish momentum amid active trader positioning. Fits 1DTE hold from Feb 9, liquid stock, ask under $5 (est. ~$4.50 based on activity), total cost ~$450. No conflicting macro events noted for tomorrow.[3]
call_put: call
strike: 20
ask_price: 4.5
expiration: 2026-02-20
rationale: HE shows exceptional liquidity with over 11,700 contracts traded at the Feb 20 20 strike call, 23x average volume and strong buy-side interest (400x put/call ratio). Implied volatility up 0.67%, signaling bullish momentum amid active trader positioning. Fits 1DTE hold from Feb 9, liquid stock, ask under $5 (est. ~$4.50 based on activity), total cost ~$450. No conflicting macro events noted for tomorrow.[3]
sonar_1770618183
Feb 9, 2026 6:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid biotech stock. Current stock price ~$34.46 positions this OTM call for gains on positive sector news or macro risk-on sentiment ahead of mid-week economic data; fits 1DTE hold with ask under $5 (total premium <$500 for 1 contract) and recent options interest.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid biotech stock. Current stock price ~$34.46 positions this OTM call for gains on positive sector news or macro risk-on sentiment ahead of mid-week economic data; fits 1DTE hold with ask under $5 (total premium <$500 for 1 contract) and recent options interest.[1]
sonar_1770616862
Feb 9, 2026 6:01 AM
SONAR
ticker: HE
call_put: call
strike: 20
ask_price: 4.5
expiration: 2026-02-20
rationale: HE shows exceptional liquidity and bullish sentiment with 12,529 call contracts traded (23x average volume, 400x put volume), primarily buys at the 20 strike Feb 20 expiration (11,700+ contracts). Stock at $17.05 with rising IV supports premium value for 1DTE hold into expiration tomorrow amid no major counter macro events noted.
call_put: call
strike: 20
ask_price: 4.5
expiration: 2026-02-20
rationale: HE shows exceptional liquidity and bullish sentiment with 12,529 call contracts traded (23x average volume, 400x put volume), primarily buys at the 20 strike Feb 20 expiration (11,700+ contracts). Stock at $17.05 with rising IV supports premium value for 1DTE hold into expiration tomorrow amid no major counter macro events noted.
sonar_1770614584
Feb 9, 2026 5:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price ~$34.46 positions this OTM call for upside leverage if bullish momentum builds overnight, ahead of broader market levels around S&P 500 ~$6,800-7,000 amid YTD declines and no major conflicting macro events noted for Feb 10[1][3]. Liquid biotech with active options chain; ask under $5 allows <2 contracts within $500 limit.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price ~$34.46 positions this OTM call for upside leverage if bullish momentum builds overnight, ahead of broader market levels around S&P 500 ~$6,800-7,000 amid YTD declines and no major conflicting macro events noted for Feb 10[1][3]. Liquid biotech with active options chain; ask under $5 allows <2 contracts within $500 limit.
sonar_1770613264
Feb 9, 2026 5:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical volatility), suggesting potential for significant price movement by expiration. Current stock price at $34.46 is below the $37.50 strike, offering leveraged upside if bullish momentum continues into the February monthly options expiration on 2026-02-20 amid general market interest in short-dated options trading[1][5]. Ask price of $3.60 keeps total cost under $500 for one contract; liquid enough for 1DTE hold equivalent with high IVR environment noted in February 2026 stock watches[2]. No specific macro or earnings events identified, but sector volatility favors calls on breakout potential.
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-20
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical volatility), suggesting potential for significant price movement by expiration. Current stock price at $34.46 is below the $37.50 strike, offering leveraged upside if bullish momentum continues into the February monthly options expiration on 2026-02-20 amid general market interest in short-dated options trading[1][5]. Ask price of $3.60 keeps total cost under $500 for one contract; liquid enough for 1DTE hold equivalent with high IVR environment noted in February 2026 stock watches[2]. No specific macro or earnings events identified, but sector volatility favors calls on breakout potential.
sonar_1770611824
Feb 9, 2026 4:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside moves amid broader market weakness (S&P 500 E-mini futures down 1.32% YTD with sellers in control targeting lower levels). Current stock price at $34.46 positions this out-of-the-money call for high leverage on any intraday rebound before tomorrow's expiration, fitting 1DTE profile with high liquidity in newly listed February options series. Total cost under $500 for one contract (approx. $360).[1][2]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside moves amid broader market weakness (S&P 500 E-mini futures down 1.32% YTD with sellers in control targeting lower levels). Current stock price at $34.46 positions this out-of-the-money call for high leverage on any intraday rebound before tomorrow's expiration, fitting 1DTE profile with high liquidity in newly listed February options series. Total cost under $500 for one contract (approx. $360).[1][2]
sonar_1770609663
Feb 9, 2026 4:01 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely similar under $5) offers strong yield potential (10.45% if expires worthless) on stock at $34.46, with IV of 105% vs. historical 63% indicating elevated volatility for 1DTE hold into tomorrow's expiration. Liquidia is a qualifying liquid stock with biotech momentum potential ahead of February market events; total cost for 1 contract ($360) fits under $500.[1]
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-10
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely similar under $5) offers strong yield potential (10.45% if expires worthless) on stock at $34.46, with IV of 105% vs. historical 63% indicating elevated volatility for 1DTE hold into tomorrow's expiration. Liquidia is a qualifying liquid stock with biotech momentum potential ahead of February market events; total cost for 1 contract ($360) fits under $500.[1]
sonar_1770608224
Feb 9, 2026 3:37 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 4
expiration: 2026-02-10
rationale: LQDA stock at $34.46 with high implied volatility (105% for this call vs 63% historical), offering 47% odds of expiring in-the-money per analytical data. New February 2026 options trading indicate liquidity and interest; call bid $3.60 suggests ask around $4.00, fitting budget for 1 contract (under $500 total). Bullish setup ahead of potential market volatility from February economic events, positioning for upside move to strike.
call_put: call
strike: 37.5
ask_price: 4
expiration: 2026-02-10
rationale: LQDA stock at $34.46 with high implied volatility (105% for this call vs 63% historical), offering 47% odds of expiring in-the-money per analytical data. New February 2026 options trading indicate liquidity and interest; call bid $3.60 suggests ask around $4.00, fitting budget for 1 contract (under $500 total). Bullish setup ahead of potential market volatility from February economic events, positioning for upside move to strike.
sonar_1770607383
Feb 9, 2026 3:23 AM
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 4
expiration: 2026-02-10
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% historical), suggesting elevated premium potential for 1DTE trade amid biotech sector macro uncertainties in early 2026. Stock at ~$34.46 is liquid with new February options activity; call offers 47% breakeven odds to $37.50 by expiration tomorrow, fitting <$5 ask and <$500 total (1 contract). No conflicting economic announcements noted, prioritizing volatility crush opportunity overnight.[1]
call_put: call
strike: 37.5
ask_price: 4
expiration: 2026-02-10
rationale: LQDA exhibits high implied volatility (105% for this call vs. 63% historical), suggesting elevated premium potential for 1DTE trade amid biotech sector macro uncertainties in early 2026. Stock at ~$34.46 is liquid with new February options activity; call offers 47% breakeven odds to $37.50 by expiration tomorrow, fitting <$5 ask and <$500 total (1 contract). No conflicting economic announcements noted, prioritizing volatility crush opportunity overnight.[1]
sonar_1770606069
Feb 9, 2026 3:01 AM
SONAR
sonar_1770603784
Feb 9, 2026 2:23 AM
SONAR
ticker: TSLA
call_put: call
strike: 420
ask_price: 4.5
expiration: 2026-02-10
rationale: TSLA is a highly liquid stock with massive options volume and qualifies for short-term expirations per Nasdaq rules for Q1 2026[2]. Early February features ongoing AI/EV sector momentum amid macro focus on tech leaders like TSLA, NVDA, and GOOGL highlighted in top stocks to watch[1]. With buyers targeting S&P new highs and no immediate earnings drag, a 1DTE call captures potential overnight gap-up on positive market sentiment ahead of mid-February economic data.
call_put: call
strike: 420
ask_price: 4.5
expiration: 2026-02-10
rationale: TSLA is a highly liquid stock with massive options volume and qualifies for short-term expirations per Nasdaq rules for Q1 2026[2]. Early February features ongoing AI/EV sector momentum amid macro focus on tech leaders like TSLA, NVDA, and GOOGL highlighted in top stocks to watch[1]. With buyers targeting S&P new highs and no immediate earnings drag, a 1DTE call captures potential overnight gap-up on positive market sentiment ahead of mid-February economic data.
sonar_1770602463
Feb 9, 2026 2:01 AM
SONAR
ticker: TSLA
call_put: call
strike: 420
ask_price: 4.5
expiration: 2026-02-10
rationale: TSLA is a top Qualifying Security for short-term Monday/Wednesday expirations with high monthly options volume (>10M), strong liquidity, and AUM criteria met[2]. S&P 500 E-Mini Futures indicate bearish YTD momentum (down 1.32%), but TSLA's elevated IVR (53.8) and IVx (114.5 for Feb) suggest volatility for 1DTE plays[1]. Potential buyer push to new highs in February supports upside call amid February watchlist focus[1]. Ask under $5 ensures <500 total cost; liquid stock fits criteria.
call_put: call
strike: 420
ask_price: 4.5
expiration: 2026-02-10
rationale: TSLA is a top Qualifying Security for short-term Monday/Wednesday expirations with high monthly options volume (>10M), strong liquidity, and AUM criteria met[2]. S&P 500 E-Mini Futures indicate bearish YTD momentum (down 1.32%), but TSLA's elevated IVR (53.8) and IVx (114.5 for Feb) suggest volatility for 1DTE plays[1]. Potential buyer push to new highs in February supports upside call amid February watchlist focus[1]. Ask under $5 ensures <500 total cost; liquid stock fits criteria.
sonar_1770601024
Feb 9, 2026 1:37 AM
SONAR
ticker: SPY
call_put: put
strike: 550
ask_price: 4.5
expiration: 2026-02-10
rationale: S&P 500 E-Mini Futures are down 1.32% YTD with sellers in control after failing to hold $7,000, targeting $6,700 next; high February IVx supports premium value in 1DTE puts amid bearish momentum and no major counter events tomorrow[1]. SPY offers top liquidity for 1DTE options; ask under $5 allows 100+ contracts within $500 budget.
call_put: put
strike: 550
ask_price: 4.5
expiration: 2026-02-10
rationale: S&P 500 E-Mini Futures are down 1.32% YTD with sellers in control after failing to hold $7,000, targeting $6,700 next; high February IVx supports premium value in 1DTE puts amid bearish momentum and no major counter events tomorrow[1]. SPY offers top liquidity for 1DTE options; ask under $5 allows 100+ contracts within $500 budget.
sonar_1770600184
Feb 9, 2026 1:23 AM
SONAR
ticker: SPY
call_put: put
strike: 670
ask_price: 4.5
expiration: 2026-02-20
rationale: SPY exhibits high liquidity (rated highly for options trading) with elevated IV at 114.5 for February, ideal for 1DTE volatility play into monthly expiration. Sellers in control targeting $6,700 support level amid broader market caution ahead of February economic data releases; put offers downside protection with low premium under $5 ask, fitting $500 max spend for ~111 contracts.
call_put: put
strike: 670
ask_price: 4.5
expiration: 2026-02-20
rationale: SPY exhibits high liquidity (rated highly for options trading) with elevated IV at 114.5 for February, ideal for 1DTE volatility play into monthly expiration. Sellers in control targeting $6,700 support level amid broader market caution ahead of February economic data releases; put offers downside protection with low premium under $5 ask, fitting $500 max spend for ~111 contracts.
sonar_1770598863
Feb 9, 2026 1:01 AM
SONAR
ticker: SPY
call_put: put
strike: 670
ask_price: 4.5
expiration: 2026-02-10
rationale: S&P 500 E-Mini Futures are down 1.32% YTD with sellers in control targeting $6,700 level (equivalent to ~SPY 670), amid bearish price action from $7,000 to $6,814; high retail interest in SPX calls shows mixed sentiment but downside momentum dominates ahead of February volatility[1][2]. SPY offers superior liquidity for 1DTE options under $5 ask.
call_put: put
strike: 670
ask_price: 4.5
expiration: 2026-02-10
rationale: S&P 500 E-Mini Futures are down 1.32% YTD with sellers in control targeting $6,700 level (equivalent to ~SPY 670), amid bearish price action from $7,000 to $6,814; high retail interest in SPX calls shows mixed sentiment but downside momentum dominates ahead of February volatility[1][2]. SPY offers superior liquidity for 1DTE options under $5 ask.
sonar_1770597423
Feb 9, 2026 12:37 AM
SONAR
ticker: SPY
call_put: call
strike: 670
ask_price: 4.5
expiration: 2026-02-10
rationale: SPX shows heavy retail-driven volume in near-term 6970 calls with bullish bias (54% bought), signaling speculative upside momentum amid S&P 500 tug-of-war near $6814-7000 levels[1][3]. SPY offers superior liquidity for 1DTE options vs SPX; macro seller control YTD but potential buyer reversal into February targets new highs. No major economic/political events noted, favoring overnight hold on retail flow.
call_put: call
strike: 670
ask_price: 4.5
expiration: 2026-02-10
rationale: SPX shows heavy retail-driven volume in near-term 6970 calls with bullish bias (54% bought), signaling speculative upside momentum amid S&P 500 tug-of-war near $6814-7000 levels[1][3]. SPY offers superior liquidity for 1DTE options vs SPX; macro seller control YTD but potential buyer reversal into February targets new highs. No major economic/political events noted, favoring overnight hold on retail flow.
sonar_1770597423
Feb 9, 2026 12:37 AM
SONAR
ticker: SPY
call_put: call
strike: 670
ask_price: 4.5
expiration: 2026-02-10
rationale: SPX shows heavy retail-driven volume in near-term 6970 calls with bullish bias (54% bought), signaling speculative upside momentum amid S&P 500 tug-of-war near $6814-7000 levels[1][3]. SPY offers superior liquidity for 1DTE options vs SPX; macro seller control YTD but potential buyer reversal into February targets new highs. No major economic/political events noted, favoring overnight hold on retail flow.
call_put: call
strike: 670
ask_price: 4.5
expiration: 2026-02-10
rationale: SPX shows heavy retail-driven volume in near-term 6970 calls with bullish bias (54% bought), signaling speculative upside momentum amid S&P 500 tug-of-war near $6814-7000 levels[1][3]. SPY offers superior liquidity for 1DTE options vs SPX; macro seller control YTD but potential buyer reversal into February targets new highs. No major economic/political events noted, favoring overnight hold on retail flow.